Concepedia

Max Kraemer

MK

Statistics

Publications

5

Citations

173

H-Index

5

Active since

2019

Affiliations

University Hospital Cologne(Current)

University of Cologne

Agaplesion Markus Hospital

Max Kraemer is an author at University Hospital Cologne specializing in medicine, tumor microenvironment, and pathology.

Top concepts

Publications per year

2019–2021

5

Publications

5

The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma

Heike Loeser, Max Kraemer, Florian Gebauer et al. · OncoImmunology · 2019 · 84 citations · Full text

, , +15

PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis

Ahlem Essakly, Heike Loeser, Max Kraemer et al. · Translational Oncology · 2019 · 32 citations · Full text

, , +18

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

Svenja Wagener‐Ryczek, Max Schoemmel, Max Kraemer et al. · Cancer Immunology Immunotherapy · 2020 · 31 citations · Full text

Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus

M. Schoemmel, Heike Loeser, Max Kraemer et al. · Clinical & Translational Oncology · 2021 · 14 citations · Full text

Indoleamine 2,3‐Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma

Heike Loeser, Max Kraemer, Florian Gebauer et al. · Journal of Immunology Research · 2020 · 12 citations · Full text

Rows per page

1–5 of 5